Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

6,477 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective.
Feng Z, Prentice R, Srivastava S. Feng Z, et al. Pharmacogenomics. 2004 Sep;5(6):709-19. doi: 10.1517/14622416.5.6.709. Pharmacogenomics. 2004. PMID: 15335291 Review.
Explaining community-level variance in group randomized trials.
Feng Z, Diehr P, Yasui Y, Evans B, Beresford S, Koepsell TD. Feng Z, et al. Stat Med. 1999 Mar 15;18(5):539-56. doi: 10.1002/(sici)1097-0258(19990315)18:5<539::aid-sim50>;2-s. Stat Med. 1999. PMID: 10209810
Selected statistical issues in group randomized trials.
Feng Z, Diehr P, Peterson A, McLerran D. Feng Z, et al. Annu Rev Public Health. 2001;22:167-87. doi: 10.1146/annurev.publhealth.22.1.167. Annu Rev Public Health. 2001. PMID: 11274517 Review.
Phases of biomarker development for early detection of cancer.
Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Pepe MS, et al. Among authors: feng z. J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61. doi: 10.1093/jnci/93.14.1054. J Natl Cancer Inst. 2001. PMID: 11459866 Review. No abstract available.
A polymorphism in the CYP17 gene and risk of prostate cancer.
Stanford JL, Noonan EA, Iwasaki L, Kolb S, Chadwick RB, Feng Z, Ostrander EA. Stanford JL, et al. Among authors: feng z. Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):243-7. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11895872
Some design issues in a community intervention trial.
Feng Z, Thompson B. Feng Z, et al. Control Clin Trials. 2002 Aug;23(4):431-49. doi: 10.1016/s0197-2456(02)00206-4. Control Clin Trials. 2002. PMID: 12161089
Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.
Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL Jr. Qu Y, et al. Among authors: feng z. Clin Chem. 2002 Oct;48(10):1835-43. Clin Chem. 2002. PMID: 12324514
Development of common data elements: the experience of and recommendations from the early detection research network.
Winget MD, Baron JA, Spitz MR, Brenner DE, Warzel D, Kincaid H, Thornquist M, Feng Z. Winget MD, et al. Among authors: feng z. Int J Med Inform. 2003 Apr;70(1):41-8. doi: 10.1016/s1386-5056(03)00005-4. Int J Med Inform. 2003. PMID: 12706181
Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data.
Qu Y, Adam BL, Thornquist M, Potter JD, Thompson ML, Yasui Y, Davis J, Schellhammer PF, Cazares L, Clements M, Wright GL Jr, Feng Z. Qu Y, et al. Among authors: feng z. Biometrics. 2003 Mar;59(1):143-51. doi: 10.1111/1541-0420.00017. Biometrics. 2003. PMID: 12762451
A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL Jr, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z. Yasui Y, et al. Among authors: feng z. Biostatistics. 2003 Jul;4(3):449-63. doi: 10.1093/biostatistics/4.3.449. Biostatistics. 2003. PMID: 12925511
6,477 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page